Cardica’s Pooled Anastomosis Device Data Fail To Connect With FDA Panel
This article was originally published in The Gray Sheet
Executive Summary
Cardica, Inc.'s PAS Port proximal anastomosis device has appeal as a less invasive alternative to suturing for coronary bypass surgery, but the firm lacks sufficient data to demonstrate safety and effectiveness, FDA's Circulatory System Devices Panel members agreed April 22